CARISMA Therapeutics Stock (NASDAQ: CARM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 39.00 / 793.68K |
Day Range | - - - |
52 Wk Range | 0.99 - 9.59 |
Market Cap | $47.76M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 5.87% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CARISMA Therapeutics (NASDAQ:CARM) through any online brokerage.
Other companies in CARISMA Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
There is no analysis for CARISMA Therapeutics.
CARISMA Therapeutics has a consensus price target of $9.20.
The stock price for CARISMA Therapeutics (NASDAQ: CARM) is $1.1497 last updated July 19, 2024 at 7:24 PM EDT.
There are no upcoming dividends for CARISMA Therapeutics.
CARISMA Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for CARISMA Therapeutics.
CARISMA Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.